The AstraZeneca vaccine, blood clots and VIPIT: What you need to know

Canada's National Advisory Committee on Immunization has recommended pausing administration of the AstraZeneca coronavirus vaccine to those under the age of 55 due to reports of blood clots occurring in vaccine recipients in Europe.